Analyst Brian Abrahams writes in a midday note that Incyte (NASDAQ: INCY) and Eli Lilly & Co. (NYSE: LLY) talks ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Hot Comments

Eli Lilly (LLY) PT Maintained at $95 at Cowen on 1Q18 Report; 'Top & Bottom Line Beat... FY18 Guidance Raised'April 24, 2018 11:50 AM Incyte (INCY) Announces Expanded Clinical Collaboration with Immunovaccine Inc. to Evaluate Combination Immunotherapies in Advanced Recurrent Ovarian CancerApril 24, 2018 7:12 AM Eli Lilly & Co. (LLY) & Incyte Corporation (INCY) Confirms FDA Advisory Committee Recommends Approval of Baricitinib 2mg and Against 4mgApril 24, 2018 6:01 AM Bari Adcom Negative for Eli Lilly (LLY) and AbbVie (ABBV), Positive for Pfizer (PFE) - BMOApril 19, 2018 9:41 AM